MassGeneral Institute for Neurodegenerative Disease

Translating today's discoveries into tomorrow's cures

Facebook icon Twitter Icon

News page banner

FDA Awards Fast Track Status to Revalesio’s RNS60 for ALS; Phase 2 Trial Recruiting – ALS News Today mentions recent MGH clinical trial

1/9/2019 - Read the full story here.